Edwin Mangune, MD
Family Medicine · Bellflower, CANPI 1003047978
Payments from drug & device makers
Across 215 payments — averaging $5794.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$763K
- Pfizer$337K
- GSK$120K
- Shionogi Inc$25K
- Lilly USA, LLC$250
- Boehringer Ingelheim$184
- plus $740 from 11 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 85 | $762,838 |
| Pfizer | 35 | $337,285 |
| GSK | 33 | $119,886 |
| Shionogi Inc | 6 | $24,636 |
| Lilly USA, LLC | 12 | $250 |
| Boehringer Ingelheim | 7 | $184 |
| Teva Pharmaceuticals USA, Inc. | 9 | $157 |
| Novo Nordisk | 8 | $157 |
| Phadia US Inc. | 4 | $74 |
| Amgen | 2 | $71 |
| AbbVie | 4 | $68 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $56 |
| Biohaven Pharmaceuticals, Inc. | 3 | $53 |
| Harmony Biosciences LLC | 1 | $34 |
| Sanofi Pasteur Inc. | 2 | $30 |
| Amarin Pharma, Inc. | 1 | $22 |
| Sarepta Therapeutics, Inc. | 1 | $16 |
How this compares
$1,245,820 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Bellflower
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
- Suzanne FussellOxnard$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.